Improving lives with precision diagnostics® for informed treatment decisions in myelo- and lympho-proliferative disorders. #Oncology #MFC #NGS #ClinicalTrials
San Diego, CA, USA
Joined March 2010
- Tweets1.8K
- Following703
- Followers551
- Likes92
Last chance! Tomorrow, Oct 28, 10am PST | 1pm EST | 6pm CEST: Alice Scarpa on #NGS-based MRD & IG/TR repertoire insights post-transplant + Dr. Svea Stratmann on implementing UHS-NGS, from baseline clonotypes to longitudinal #MRD. #Invivoscribe
Register: na2.hubs.ly/H08FpZ30
Today is #MDSWorldAwarenessDay.
#MDS are rare blood cancers where bone marrow stops making healthy blood cells. Early signs like fatigue and bruising are often missed, and MDS can progress to #AML. Proud to stand with the MDS Alliance.
#BloodCancer #Invivoscribe
How sensitive does your #MRD assay need to be? Wed, Oct 28, Dr. Svea Stratmann & Alice Scarpa share a lab-tested look at moving from PCR to UHS-NGS for clonality & MRD in ALL/CLL.
🗓️ 10am PST | 1pm EST | 6pm CEST
Register: na2.hubs.ly/H08ypK40
#Invivoscribe #NGS #MRD
#Clonality results shouldn’t depend on subjective interpretation. #LymphoTrack® Flex assays + software deliver standardized analysis & objective results across 7 Ig/TCR targets. na2.hubs.ly/H08xcMY0 For RUO Only. Not for use in diagnostic procedures. #Invivoscribe #NGS
Visiting #ASHG2026 in Montréal? Stop by the #Invivoscribe poster: LymphoTrack® Enterprise Software for quantitative MRD, CLL subset classification & Ig/TCR repertoire diversity.
📆 Wed, Oct 21, 2:30 PM📍 Board 2032W
#MRD #CLL #ImmuneRepertoire #NGS #Bioinformatics
Moving from PCR to #NGS for #MRD changes how you validate, set your limit of detection & choose clonal markers. Our webinar gives labs a realistic roadmap. 📅 Oct 28 | 10am PT / 1pm ET / 6pm CEST Register: na2.hubs.ly/H08n_kc0
#Invivoscribe #ClonalityTesting #Hematology
Heading to #ASHG2026 in Montréal? Catch the #Invivoscribe poster on #LymphoTrack® Enterprise Software: automated, high-throughput analysis for B- & T-cell #NGS clonality, incl. quantitative MRD & CLL subsets. 📆Wed, Oct 21, 2:30 PM📍Board 2032W, Poster Hall
#PrecisionDiagnostics
Introducing LymphoTrack® Flex: bring clonality, SHM & ultra-high sensitivity NGS testing in-house. Flexible DNA input, scalable multiplexing, automation-ready, results in <50 hrs. More control, faster TAT, confident MRD detection.
na2.hubs.ly/H08ncTF0
#NGS #MRD #Clonality
#Invivoscribe is heading to Seattle for #AMP2026!
📍 Booth #637: sample prep to ultra-high sensitivity MRD
⚙️ Workshop: Wed 11/11, 4–5 PM, Tahoma 1,
📊 Posters TT023 (Fri 11/13), TT019, TT025, TT031 (Sat 11/14), 9:15 AM
We can't wait to see you in Seattle!
Is your lab ready to move beyond PCR? Join Dr. Svea Stratmann & Alice Scarpa on Oct 28 (10am PT | 1pm ET) for A Practical Path to NGS: Clonality & Ultra-High Sensitivity MRD in Lymphoid Malignancies.
Register: na2.hubs.ly/H08h9_S0
#NGS #MRD #Hematopathology #Invivoscribe
That's a wrap on #ICCS2026! Thanks to all who visited booth #405 in Miami and to Dr. Hong Drum of #LabPMM for joining us. Missed us? Explore our standardized MFC assays for heme screening, AML MRD & CLL MRD: na2.hubs.ly/H08fsdw0
#FlowCytometry #MRD #Invivoscribe
Objective clonality assessments and ultra-high sensitivity #MRD in one #NGS workflow.
LymphoTrack® Flex suite brings 7 IG/TCR targets in a scalable, automation-friendly workflow for #clonality, SHM, and sequence-based #MRD analysis.
Read more: na2.hubs.ly/H08c_NR0
We’re still at #EA4HP2026 in Berlin today and tomorrow 👋
Stop by the Invivoscribe booth to learn about UHS molecular testing for hematologic malignancies and preview the automated #PrepQuant™ System ahead of its 2027 European launch.
na2.hubs.ly/H08bg5B0
#MRD #AML #NGS
We're in Berlin at #EA4HP2026
Visit #Invivoscribe at Booth #1 for ultrasensitive molecular testing in AML, CLL, ALL, lymphoma & myeloma incl. #FLT3 ITD, NPM1 & #KMT2A plus our automated #PrepQuant System.
Preview it before its early 2027 EU launch: na2.hubs.ly/H089PQz0
High-quality results start before analysis begins. At #EA4HP2026 Berlin, #Invivoscribe previews #PrepQuant™ ahead of its Jan 2027, EU launch: #automated extraction, concentration & quantification for blood, marrow & plasma. Visit Booth #1!
na2.hubs.ly/H087KBV0 #MRD #NGS #AML
#BloodCancerAwarenessMonth ends, but progress against #leukemia, #lymphoma & #myeloma continues, one standardized test at a time. #Invivoscribe delivers globally standardized testing for reliable results worldwide. na2.hubs.ly/H083zX_0
#MRD #AML #CLL #ALL #NHL #Myeloma
Heading to #ICCS2026 in Miami! Meet Dr. Hong Drum of #LabPMM at booth #405 to explore our globally standardized MFC assays for #AML & #CLL #MRD.
Let's talk Flow! na2.hubs.ly/H082xbK0
#Invivoscribe #Diagnostics #PrecisionMedicine #Oncology #FlowCytometry #Hematopathology
Headed to Berlin for #EA4HP2026! Visit #Invivoscribe at Booth #1 for ultrasensitive molecular testing in AML, CLL, ALL, lymphoma & myeloma incl. #FLT3 ITD, NPM1 & #KMT2A, plus our automated #PrepQuant™ System. Preview it before its early 2027 EU launch: na2.hubs.ly/H080R8c0